Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with Nivolumab.

× No keyword cloud information.

7 in total

Review 1. How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy.

Authors: Yiming Ma; Qiwei Wang; Qian Dong; Lei Zhan; Jingdong Zhang
Journal: Am J Cancer Res Date: 2019-08-01 Impact factor: 6.166

2. PET/CT and the Response to Immunotherapy in Lung Cancer.

Authors: Laura Evangelista; Matteo Sepulcri; Giulia Pasello
Journal: Curr Radiopharm Date: 2020

Review 3. Curative effect assessment of immunotherapy for non-small cell lung cancer: The "blind area" of Immune Response Evaluation Criteria in Solid Tumors (iRECIST).

Authors: Peng Song; Jingcheng Zhang; Congcong Shang; Li Zhang
Journal: Thorac Cancer Date: 2019-02-19 Impact factor: 3.500

4. [A Case of Pseudoprogression During Atezolizumab Therapy  in Lung Adenocarcinoma].

Authors: Xue Wang; Yi Zhao; Zhiwei Chen
Journal: Zhongguo Fei Ai Za Zhi Date: 2019-06-20

5. Case Report: Transformation From Cold to Hot Tumor in a Case of NSCLC Neoadjuvant Immunochemotherapy Pseudoprogression.

Authors: Wenxiao Jia; Hui Zhu; Qianqian Gao; Jian Sun; Fujian Tan; Qun Liu; Hongbo Guo; Jinming Yu
Journal: Front Immunol Date: 2021-02-17 Impact factor: 7.561

6. The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy.

Authors: Wenxiao Jia; Qianqian Gao; Anqin Han; Hui Zhu; Jinming Yu
Journal: Cancer Biol Med Date: 2019-11 Impact factor: 4.248

Review 7. Patient Selection for Local Aggressive Treatment in Oligometastatic Non-Small Cell Lung Cancer.

Authors: Raphael S Werner; Isabelle Opitz
Journal: Cancers (Basel) Date: 2021-12-19 Impact factor: 6.639